Source: WND By Elizabeth Lee Vliet, M.D.

Stunning positive news on hydroxychloroquine (HCQ) was released in early July, potentially opening up medical freedom at the time of America’s celebration of our Declaration of Independence from British tyranny 244 years ago.

During the first six days of July, SIX positive clinical studies of HCQ were released:

  • three from the United States (one from Michigan at Henry Ford Health System, and two from New York state, including one primary care outpatient study by Dr. Vladimir Zelenko;
  • three from other countries (PortugalIndia and Brazil).

All six studies showed that HCQ given early in COVID-19, alone or with zinc and azithromycin, reduces hospitalizations and deaths, with no serious heart or other adverse events.

Most media ignored these six positive studies, continuing to focus on fearmongering about HCQ “dangers” from now discredited, poorly designed and seriously flawed reports on use in critically ill hospitalized patients.

The Henry Ford study showed a 50% reduction in the death rate when HCQ was used early in hospitalized COVID patients. Dr. Zelenko’s even earlier outpatient intervention with HCQ, azithromycin and zinc showed approximately 80% decrease in deaths. These extraordinary results show how many lives can be saved with early HCQ treatment.

Henry Ford physicians, researchers and ethicists have filed an urgent application with FDA Commissioner Dr. Hahn for a new Emergency Use Authorization (EUA) for early, out-patient HCQ use in COVID-19.

Baylor Scott & White Heart and Vascular Institute in Dallas issued an urgent letter in support of the Henry Ford new outpatient EUA application, based on the remarkably positive outcomes in their own clinical study of prophylactic use of HCQ in their own medical workers.

Baylor’s letter, from one of their cardiologists, showed benefit for a weekly prophylaxis regimen and described no adverse cardiac outcomes. This directly rebuts the constant media hype about “heart dangers” of HCQ.

Baylor’s report of prophylactic benefits is profoundly important, not only for front-line medical workers, but also for law enforcement officers, paramedics, dentists/dental hygienists, truck drivers, food-processing workers, clergy, behavioral health professionals, factory and grocery store workers, essential distribution centers and many others.

These respected institutions add further credibility to my April 10 letter to President Trump, which was signed by 1,305 physicians, medical workers and concerned patients asking for this new EUA.

The Henry Ford and Baylor studies add safety data to that accumulated since HCQ was first FDA-approved in 1955, as well as safety reported in 2020 COVID-19 worldwide clinical outcomes, and the safety summaries of HCQ compared to current over-the-counter medicines presented to the Trump administration May 25.

Americans urgently need to see this new and encouraging information to help relieve anxiety and fear about coronavirus. The mainstream media is still suppressing such information, which can both save lives and help America reopen safely.

Since it was approved more than 65 years ago for malaria, and later for lupus and rheumatoid arthritis, HCQ has been safely used worldwide in hundreds of millions of patients. More than 15 years ago, in the 2002-2003 SARS-CoV-1 outbreak, CDC conducted in-vitro studies that showed HCQ was a potent anti-viral agent. Since the SARS-CoV-2 virus, initially recognized in China, has been spreading around the world, HCQ has been widely used in dozens of countries as a safe and effective treatment for the novel coronavirus causing COVID-19.

In all reports, including the CDC findings published in 2005, HCQ’s most important effect is to block viral entry into the cells and viral replication IF given within the first five days of symptoms. Restricting HCQ use to only critically ill hospitalized patients has been one of the reasons for the high U.S. COVID death rate compared to countries using it prophylactically and early in the viral illness. ALL viral illness we treat respond best to anti-viral medication begun early, not late when patients are critically ill.

The U.S. situation is out of control, with people dying and businesses shut down because of FDA roadblocks and governors’ restrictive orders illegally overriding normal FDA regulations that allow physicians to prescribe any FDA-approved medication (including HCQ) however they deem medically appropriate. Physicians in many states also face threats of investigation by their state medical boards for prescribing HCQ for COVID-19, and state pharmacy boards direct pharmacists to refuse to dispense HCQ for COVID patients. Such political interference with doctors’ ability to treat patients has never happened before in my medical career.

At some point, the Trump administration has to take charge of this interference with effective medical treatment that is costing lives, and rein in the FDA and the state-by-state bureaucratic HCQ restrictions.

We need a massive grassroots effort to speak up on the FDA and White House websites in support of this new EUA Application from Henry Ford and Baylor physicians. We must push for White House officials to see the urgency we physicians, patients, and our country are facing.

Our health, our freedom, and our very lives are all at stake.


Related: Zelenko study: COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin; A Retrospective Case Series Study

Bombshell: Media disinformation proven false as Henry Ford Health study finds Hydroxychloroquine lowers COVID-19 death rate.

Zelenko’s Protocol explained: over 2200 outpatients treated with 99.7% survival rate

France 24: Hydroxychloroquine effective in treating COVID-19, according to study of 2,500

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories